Osteoarthritis, also known as degenerative arthritis degenerative joint disease, is the most common kind of arthritis that plagues approximately 27 million people in the United States, according to countrywide statistics reports. It is a joint problem that gradually worsens over time, brought about by inflammation, breakdown, and eventual loss of cartilage in the joints, as was cited by medical journals. The condition may be managed through different treatment options ranging from exercises programs, medications, physical therapy, and in some situations surgical procedures such as total hip replacement.
In a hip replacement surgery, also known as arthroplasty, the defective hip joint is replaced with an articifial hip implant. ASR hips, developed and marketed by one of the world’s major manufacturers, Johnson & Johnson (J&J), are some of the popular hip replacement in the consumer market. However, two hip implants from the ASR system, such as the ASR XL Acetabular System and the ASR Hip Resurfacing System, have been voluntarily recalled by J&J following study results that suggest notably high early failure rates from these devices.